134 related articles for article (PubMed ID: 38315951)
1. Stage Classification and Prognosis Assessment in Localized Pancreatic Cancer: It Takes Two to Tango.
Milella M
J Clin Oncol; 2024 Apr; 42(12):1331-1334. PubMed ID: 38315951
[No Abstract] [Full Text] [Related]
2. Features of Immune Cells and the Tumor-Associated Stroma Tango as Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma.
Sonohara F; Goel A
Gastroenterology; 2018 Nov; 155(5):1312-1314. PubMed ID: 30300611
[No Abstract] [Full Text] [Related]
3. [A new classification of pancreatic cancer to guide operative decisions and the comparison with the TNM stage].
Qin R
Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):488-91. PubMed ID: 26359069
[TBL] [Abstract][Full Text] [Related]
4. [New classification of the T category for pancreatic cancer].
Oshima K; Nakao A
Nihon Geka Gakkai Zasshi; 2000 Feb; 101(2):195-9. PubMed ID: 10734636
[TBL] [Abstract][Full Text] [Related]
5. Tumor grade as significant prognostic factor in pancreatic cancer: validation of a novel TNMG staging system.
Hlavsa J; Cecka F; Zaruba P; Zajak J; Gurlich R; Strnad R; Pavlik T; Kala Z; Lovecek M
Neoplasma; 2018; 65(4):637-643. PubMed ID: 30064236
[TBL] [Abstract][Full Text] [Related]
6. A new endoscopic ultrasonography image processing method to evaluate the prognosis for pancreatic cancer treated with interstitial brachytherapy.
Xu W; Liu Y; Lu Z; Jin ZD; Hu YH; Yu JG; Li ZS
World J Gastroenterol; 2013 Oct; 19(38):6479-84. PubMed ID: 24151368
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of αTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection.
Lin C; Zhao GC; Xu YD; Wang DS; Jin DY; Ji Y; Lou WH; Wu WC
Oncotarget; 2016 Sep; 7(37):60657-60664. PubMed ID: 27447976
[TBL] [Abstract][Full Text] [Related]
8. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.
Bae JS; Kim JH; Joo I; Chang W; Han JK
Eur Radiol; 2019 Jul; 29(7):3714-3724. PubMed ID: 30899975
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
10. Staging of exocrine pancreatic carcinoma.
Hermanek P
Eur J Surg Oncol; 1991 Apr; 17(2):167-72. PubMed ID: 2015921
[TBL] [Abstract][Full Text] [Related]
11. A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study.
Zhang X; Song J; Liu P; Mazid MA; Lu L; Shang Y; Wei Y; Gong P; Ma L
BMC Endocr Disord; 2018 Oct; 18(1):73. PubMed ID: 30340569
[TBL] [Abstract][Full Text] [Related]
12. New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [].
Wang M; Ding D; Qin T; Wang H; Liu Y; Liu J; Liu J; Zhang H; Zhao J; Wu CH; Javed A; Wolfgang C; Guo S; Chen Q; Zhao W; Shi W; Zhu F; Guo X; Li X; He R; Xu S; Edil B; Tien YW; Jin G; Zheng L; He J; Qin R;
Cancer Lett; 2021 Oct; 518():207-213. PubMed ID: 34271105
[TBL] [Abstract][Full Text] [Related]
13. [Does the new UICC classification allow better prognostic assessment for ductal pancreatic carcinoma?].
Ott K; Böttcher K; Werner M; Busch R; Roder JD
Chirurg; 2000 Feb; 71(2):189-95. PubMed ID: 10734588
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients.
Balzano G; Bassi C; Zerbi A; Falconi M; Calori G; Butturini G; Leone BE; Pederzoli P; Di Carlo V
Int J Pancreatol; 1997 Apr; 21(2):111-8. PubMed ID: 9209952
[TBL] [Abstract][Full Text] [Related]
15. Staging systems for pancreatic cancer: differences between the Japanese and UICC systems.
Kobari M; Matsuno S
J Hepatobiliary Pancreat Surg; 1998; 5(2):121-7. PubMed ID: 9745076
[TBL] [Abstract][Full Text] [Related]
16. [Pancreatic cancer. Molecular and surgical pathology].
Tannapfel A
Pathologe; 2010 Oct; 31 Suppl 2():225-8. PubMed ID: 20669020
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Pedersen IS; Krarup H; Thorlacius-Ussing O
Int J Cancer; 2017 Dec; 141(12):2489-2497. PubMed ID: 28857158
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
[TBL] [Abstract][Full Text] [Related]
19. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry.
Lu TP; Wu CH; Chang CC; Chan HC; Chattopadhyay A; Lee WC; Chiang CJ; Lee HY; Tien YW
Ann Surg Oncol; 2022 Mar; 29(3):1608-1615. PubMed ID: 34775547
[TBL] [Abstract][Full Text] [Related]
20. The role of morphometry in predicting prognosis in pancreatic islet cell tumors.
Kenny BD; Sloan JM; Hamilton PW; Watt PC; Johnston CF; Buchanan KD
Cancer; 1989 Jul; 64(2):460-5. PubMed ID: 2544252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
